Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea

NCT03471871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea
Healthy Subjects

Interventions

DRUG: Placebo
DRUG: Lemborexant 10 mg
DRUG: Lemborexant 25 mg
DRUG: Placebo
DRUG: Lemborexant 10 mg

Sponsor

Eisai Inc.

Collaborators

[object Object]